Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EEG predictors of methylphenidate response in children with ADHD
NL-OMON26488Active, not recruiting
- Sponsor
- Utrecht Institute for Pharmaceutical Sciences
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Utrecht Institute for Pharmaceutical Sciences. Primary endpoints: Absolute EEG power and Relative EEG power. Started May 2007; status: active, not recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON26488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26488.